Phase II studies of docetaxel in the treatment of various solid tumours
- 1 October 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31, S21-S24
- https://doi.org/10.1016/0959-8049(95)00362-m
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC early clinical trials groupEuropean Journal Of Cancer, 1994
- Taxotere is active in advanced gastric carcinoma: Results of a phase II clinical trialEuropean Journal Of Cancer, 1993
- Taxotere in the treatment of advanced colorectal carcinomaEuropean Journal Of Cancer, 1993
- Taxotere toxicity — Protective effects of premedicationEuropean Journal Of Cancer, 1993
- Phase II study with taxotere(RP56976) in advanced soft tissue sarcomas of the adultEuropean Journal Of Cancer, 1993
- Taxotere in advanced malignant melanoma: A fase-II trial of the eortc early clinical trials groupEuropean Journal Of Cancer, 1993
- A phase II study of taxotere in patients with advanced head and neck cancerEuropean Journal Of Cancer, 1993
- Taxotere (T) advanced renal cell carcbona (RCC). A phase II troal of the eortc early clincal trials groupEuropean Journal Of Cancer, 1993
- Patient perception of the side effects of chemotherapy; the influence of the introduction of 5TH3 antagonistsEuropean Journal Of Cancer, 1993
- Chemotherapy in the multidisciplinary approach to soft tissue sarcomasAnnals of Oncology, 1992